Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical and clinical re

Comments · 21 Views

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain.

Given the complex RD protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.

 

To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

The USD 15.7 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

  • Phase of Development
  • Clinical
  • Preclinical

 

  • Types of Preclinical Services Offered
  • Biocompatibility testing
  • Sterility and microbiology testing
  • Material characterization and analytical services
  • Others

 

  • Types of Clinical Services Offered
  • Clinical trial management
  • Data management
  • Regulatory affairs management
  • Consulting
  • Others

 

  • Device Class
  • Class I medical devices
  • Class II medical devices
  • Class III medical devices

 

  • Target Therapeutic Area
  • CNS disorders
  • Cardiovascular disorders
  • Oncological disorders
  • Bone disorders
  • Respiratory disorders
  • Pain management disorders
  • Ophthalmic disorders
  • Psychological disorders
  • Metabolic disorders
  • Others

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

The Medical Device CRO Market (2nd Edition), 2020-2030”. report features the following companies, which we identified to be key players in this domain:

  • Avania (formerly known as Factory CRO)
  • Charles River Laboratories
  • Clinlogix
  • CROMSOURCE
  • CSSi LifeSciences™
  • Eurofins Medical Device Testing
  • genae
  • IMARC Research
  • IQVIA
  • Medpace
  • NAMSA
  • Qserve Group
  • Regulatory and Clinical Research Institute (now a part of Covance)
  • WuXi AppTec

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction
  3. Market Landscape
  4. Regulatory and Reimbursement Landscape for Medical Devices
  5. Company Profiles
  6. Medical Device Developer and CRO Relationships: Key Value Drivers and Performance Indicators
  7. Competitive Benchmarking
  8. Brand Positioning of Key Industry Players
  9. Clinical Trial Analysis
  10. Mergers and Acquisitions
  11. Survey Insights
  12. Market Sizing and Forecast
  13. Case Study: Impact of Coronavirus Outbreak

 

  1. SWOT Analysis

 

  1. Future Trends and Opportunities

 

  1. Interview Transcripts

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Comments